InvestorsHub Logo
Followers 18
Posts 1737
Boards Moderated 0
Alias Born 09/26/2018

Re: HDGabor post# 262361

Sunday, 04/05/2020 2:23:56 PM

Sunday, April 05, 2020 2:23:56 PM

Post# of 425795
Quite:

Applicant was able to overcome the above 103 obviousness rejection by showing: … The prior art is either silent or teaches that there is no statistically significant change in Apo-B levels when patients with TG levels less than 150 mg/dl or between 150-499 mg/dl are treated with either 96% pure ethyl-EPA or a mixture of ethyl-EPA and DHA

Kurabayashi teaches differently:_ ss changes in Apo-B exist.

Hdg,

Can we say we have established per mc1988 that Kura did not reach us there is ss apoB reduction with epa, instead of e + epa (not epa + e either,seems to me more focus on e for this study)

Kura trial base line trig: 150 - 400, study group: 1800mg epa + 2mg e, purity 99.8%
Control group: 2mg e only?

I am wondering where re those number coming from in PTO quote: 150, 499 and 96%. He gave no reference, maybe you can find them. Thanks a lot for doing this by the way.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News